Fixed‐dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia

Hypertension and dyslipidemia are important risk factors for cardiovascular disease. However, the clinical outcomes of fixed‐dose combination (FDC) versus free‐equivalent combination (FEC) of amlodipine and atorvastatin in the treatment of concurrent hypertension and dyslipidemia remain unknown. In...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Hypertens (Greenwich)
Glavni autori: Lin, Chia‐Pin, Tung, Ying‐Chang, Hsiao, Fu‐Chih, Yang, Chia‐Hung, Kao, Yi‐Wei, Lin, Yu‐Sheng, Chu, You‐Chia, Chu, Pao‐Hsien
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Combination Therapy
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8029959/
https://ncbi.nlm.nih.gov/pubmed/32862551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.14016
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items